These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Pseudo-cardioversion of atrial fibrillation. Cheng TO Int J Cardiol; 2005 May; 101(2):305. PubMed ID: 15882680 [No Abstract] [Full Text] [Related]
26. [Importance of experimental studies on anti-arrhythmia agents and their clinical use]. Williams EM Coeur Med Interne; 1978; 17(4):471-89. PubMed ID: 737992 [No Abstract] [Full Text] [Related]
27. [Effects of denudatine on experimental arrhythmia and heart function (author's transl)]. Jin LS; Zhou YP; Zeng GY Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):104-8. PubMed ID: 6214142 [No Abstract] [Full Text] [Related]
28. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives]. Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacology and classification of anti-arrhythmia agents]. Giudicelli JF; Lhoste F Rev Prat; 1975 Oct; 25(45):3449-52, 3455-8. PubMed ID: 1209115 [No Abstract] [Full Text] [Related]
30. [Mechanism of action of antiarrhythmic agents]. Méndez R Arch Inst Cardiol Mex; 1977; 47(2):223-32. PubMed ID: 901057 [No Abstract] [Full Text] [Related]
31. [Synthesis and anti-arrhythmia activity of 5-benzylidene-imidazoline-4-one derivatives]. Bousquet E; Pappalardo G Boll Chim Farm; 1979 Jan; 118(1):23-7. PubMed ID: 454527 [No Abstract] [Full Text] [Related]
32. [Classification of anti-arrhythmia agents and their characteristics]. Hayakawa H Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1022-5. PubMed ID: 1680943 [No Abstract] [Full Text] [Related]
33. The relationship of lower heart rate to mortality and the benefits of exclusive heart rate reduction in ischaemia. Cardiovasc J Afr; 2007; 18(5):338-40. PubMed ID: 17985037 [No Abstract] [Full Text] [Related]
34. [Sodium channels and anti-arrhythmia agents. Time for a new classification?]. Elinder F; Arhem P Lakartidningen; 1993 Dec; 90(50):4545-9. PubMed ID: 8264290 [No Abstract] [Full Text] [Related]
36. [Classification of anti-arrhythmia drugs and their dosage]. Sanna GP Cardiol Prat; 1970 Aug; 21(4):283-7. PubMed ID: 5495421 [No Abstract] [Full Text] [Related]
37. [Chronotropic and inotropic dependence of the myocardium in patients with rheumatic heart disease before and after amiodarone treatment]. Kondrat'eva DS; Afanas'ev SA; Evtushenko AV; Evtushenko VV; Shipulin VM Fiziol Cheloveka; 2008; 34(1):52-6. PubMed ID: 18365633 [No Abstract] [Full Text] [Related]
38. [Isoptin studies on normal subjects and patients with coronary disease]. Knoch G; Schlepper M; Witzleb E Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185 [No Abstract] [Full Text] [Related]
39. [Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)]. Breithardt G; Gleichmann U; Seipel L; Loogen F Z Kardiol; 1974 May; 63(3):435-44. PubMed ID: 4608660 [No Abstract] [Full Text] [Related]